Exhibit 99.1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be...Joint Filing Agreement • April 13th, 1999 • Vertical Fund Associates L P • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed on their behalf with respect to the beneficial ownership of any equity securities of Lifecore Biomedical, Inc. or any subsequent acquisitions or dispositions of equity securities of Lifecore Biomedical, Inc. by any of the undersigned.
Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed...Joint Filing Agreement • August 26th, 1999 • Vertical Fund Associates L P • Orthopedic, prosthetic & surgical appliances & supplies
Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed on their behalf with respect to the beneficial ownership of any equity securities of Innovasive Devices, Inc. or any subsequent acquisitions or dispositions of equity securities of Innovasive Devices, Inc. by any of the undersigned.
Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed...Joint Filing Agreement • August 18th, 1997 • Vertical Fund Associates L P • Services-facilities support management services
Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed on their behalf with respect to the beneficial ownership of any equity securities of VitalCom Inc. or any subsequent acquisitions or dispositions of equity securities of VitalCom Inc. by any of the undersigned.
Joint Filing AgreementJoint Filing Agreement • June 21st, 2005 • Vertical Fund I Lp • Surgical & medical instruments & apparatus
The undersigned hereby agree that the statement on Schedule 13D with respect to the common stock, par value $0.01 per share, of ev3 Inc., a Delaware corporation, is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended.
STOCK SALE PLANStock Sale Plan • January 29th, 2002 • Vertical Fund I Lp • Biological products, (no disgnostic substances)
Exhibit A --------- February 15, 2005 Piper Jaffray & Co. Banc of America Securities LLC As Representatives of the Several Underwriters c/o Piper Jaffray & Co. 800 Nicollet Mall Minneapolis, MN 55402 Re: ev3 Inc. (as the successor to the merger of ev3...Underwriting Agreement • June 21st, 2005 • Vertical Fund I Lp • Surgical & medical instruments & apparatus
Piper Jaffray & Co. Banc of America Securities LLC As Representatives of the Several Underwriters c/o Piper Jaffray & Co. 800 Nicollet Mall Minneapolis, MN 55402
Vertical Stock Sale PlanStock Sale Plan • February 28th, 2003 • Vertical Fund I Lp • Biological products, (no disgnostic substances)
This Stock Sale Plan (this “Plan”) is entered into this 21st day of February, 2003 between Vertical Fund I, L.P. & Vertical Fund II, L.P. (together, the “Participant”) and U.S. Bancorp Piper Jaffray Inc. (the “Broker”).
